Enveric Biosciences, Inc. (ENVB) › Operating IncomeEnveric Biosciences, Inc. (ENVB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$35.9K2011: -$31.4K2012: -$22.7K2013: $27.2K2014: $32.8K2015: -$794.0K2016: -$5.38M2017: -$10.90M2018: -$7.15M2019: -$2.30M2020: -$5.62M2021: -$64.62M2022: -$27.42M2023: -$16.45M2024: -$9.63M2025: -$8.77M-$8.77M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$8.77M+8.9%2024-$9.63M+41.4%2023-$16.45M+40.0%2022-$27.42M+57.6%2021-$64.62M-1050.4%2020-$5.62M-144.6%2019-$2.30M+67.9%2018-$7.15M+34.4%2017-$10.90M-102.5%2016-$5.38M-577.6%2015-$794.0K-2519.9%2014$32.8K+20.6%2013$27.2K+219.9%2012-$22.7K+27.7%2011-$31.4K+12.5%2010-$35.9K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share